Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Genital Diseases, Male × Pluvicto × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 30 Metastatic Castration-resistant Prostate Cancer 5 Kidney Neoplasms 2 Carcinoma, Renal Cell 2 Urogenital Neoplasms 1 Thrombocytopenia 1 Renal Insufficiency 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Neoplasms by Site 1 Neoplasms 1 Metastatic Hormone Naive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Male Urogenital Diseases 1 Liver Neoplasms 1 Glioma 1 Glioblastoma 1 Genital Neoplasms, Male 1 Disease 1 Cytopenia 1 Carcinoma, Hepatocellular 1 Astrocytoma 1 Anemia 1

Interventions

gedatolisib 1 gallium 68 PSMA-11 1 darolutamide 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡